This opportunity is no longer accepting applications.
grant PAR-23-148

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

This grant opportunity supports research on the long-term heart and lung health effects in people treated for tuberculosis (TB). Researchers are encouraged to study existing groups of adult or child TB patients to better understand negative health outcomes after treatment, whether they have HIV or not.

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection i…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR

Dates

Opportunity Released: March 30, 2023
Open for Submission: March 30, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.